Stay updated on Tipifarnib and Alpelisib in R/M HNSCC Clinical Trial
Sign up to get notified when there's something new on the Tipifarnib and Alpelisib in R/M HNSCC Clinical Trial page.
Latest updates to the Tipifarnib and Alpelisib in R/M HNSCC Clinical Trial page
- Check2 days agoChange DetectedThe website has updated its contact information and principal investigators, with a new version (v2.14.0) released, while removing previous entries and consolidating the format.SummaryDifference12%
- Check10 days agoNo Change Detected
- Check17 days agoChange DetectedNew estimated update dates have been added for late 2024 and mid-2025, while several October 2023 dates and a previous update notice have been removed.SummaryDifference1%
- Check24 days agoNo Change Detected
- Check31 days agoChange DetectedThe website has been updated from version 2.13.2 to 2.13.3.SummaryDifference0.1%
- Check38 days agoChange DetectedThe website has updated the contact details section for the study, clarifying that it now provides information for individuals who can answer questions about joining the study, along with a reference to the Contacts and Locations section.SummaryDifference3%
- Check53 days agoChange DetectedThe website has removed several key links related to genetics and health resources, including MedlinePlus and NIH, along with various data fields and options for downloading study information.SummaryDifference4%
- Check60 days agoChange DetectedNew resources related to genetics and health have been added, including links to MedlinePlus and various government health websites.SummaryDifference0.3%
Stay in the know with updates to Tipifarnib and Alpelisib in R/M HNSCC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Tipifarnib and Alpelisib in R/M HNSCC Clinical Trial page.